Pulmonary metastatic melanoma: current state of diagnostic imaging and treatments.
| Autor: | Zhang KS; Department of Internal Medicine, Virginia Tech Carilion School of Medicine, Roanoke, VA 24016, USA., Pelleg T; Samaritan Health Services, Corvallis, OR 97330, USA., Campbell S; Department of Pulmonary & Sleep Medicine, Carilion Clinic, Roanoke, VA 24016, USA., Rubio C; Department of Basic Science Education, Liberty University College of Osteopathic Medicine, Lynchburg, VA 24502, USA., Loschner AL; Samaritan Health Services, Corvallis, OR 97330, USA.; Department of Pulmonary & Sleep Medicine, Carilion Clinic, Roanoke, VA 24016, USA., Ie S; Samaritan Health Services, Corvallis, OR 97330, USA.; Department of Pulmonary & Sleep Medicine, Carilion Clinic, Roanoke, VA 24016, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Melanoma management [Melanoma Manag] 2021 Jul 09; Vol. 8 (3), pp. MMT58. Date of Electronic Publication: 2021 Jul 09 (Print Publication: 2021). |
| DOI: | 10.2217/mmt-2021-0001 |
| Abstrakt: | Melanoma is the deadliest form of skin cancer with an estimated incidence of over 160,000 cases annually and about 41,000 melanoma-related deaths per year worldwide. Malignant melanoma (MM) primarily occurs in the skin but has been described in other organs. Although the respiratory system is generally afflicted by tumors such as lung cancer, it is also rarely affected by primary MM. The estimated incidence of pulmonary MM of the lung accounts for 0.01% of all primary lung tumors. The current understanding of pulmonary MM of the lung pathophysiology and its management are not well established. We aim to survey current clinical modalities with a focus on diagnostic imaging and therapeutic intervention to guide providers in the management of patients with a high index of suspicion. Competing Interests: Financial & competing interests disclosure The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript. (© The authors.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|